Express News | Baiyun Mountain: Wang Laoji at the Sino-French Food Carnival
Baiyun Mountain (600332): Steady growth in 24Q1 performance promotes high-quality development
Incident: Baiyunshan Company released its report for the first quarter of 2024. In 2024Q1, the company achieved revenue of 22.946 billion yuan (+6.09%), net profit to mother of 1,958 billion yuan (+2.59% year over year), deducted from non-return
Express News | Baiyun Mountain: Wang Laoji collaborates with KFC
Baiyun Mountain (600332): 1Q24 results are in line with expectations, the cost rate declined year-on-year
The results for the first quarter of 2024 are in line with our expectations. The company announced the results for the first quarter of 2024: operating income of 22.95 billion yuan, up 6.09% year on year; net profit to mother was 1.96 billion yuan, up 2.59% year on year, right
Featured announcements | The total amount of AIA share repurchase plans increased to US$12 billion; Sinopec's net profit for the first quarter decreased 8.9% year-on-year
China Shenhua's net profit for the first quarter was 15.884 billion yuan, a year-on-year decrease of 14.7%; China Life Insurance's net profit for the first quarter was 20.644 billion yuan, a decrease of 9.3% year-on-year.
Express News | Lingnan Holdings: Guangzhou Travel Yuejing Company plans to acquire 100% of Baiyunshan Travel Development's shares for 6.151,800 yuan
白雲山:2024年第一季度報告
Baiyun Mountain (00874): Mingxing Pharmaceutical's dopamine hydrochloride injection obtained approval for drug supplementation
Baiyunshan (00874) announced that recently, Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company (hereinafter referred to as...
Baiyun Mountain (00874) plans to renew the employment of Daxin Certified Public Accountants
According to Zhitong Finance App, Baiyunshan (00874) announced that the company plans to renew Daxin Certified Public Accountants (Special General Partnership) as an accounting firm.
Express News | Baiyunshan: Net profit from mother for the first quarter was 1,958 billion yuan, up 2.59% year on year
Featured announcements | Zijin Mining's Q1 net profit increased 15% year over year; Bubble Mart's overseas revenue increased by more than 240% in the first quarter
China Mobile's Q1 net profit increased 5.5% year over year to 29.6 billion yuan; Chabaidao's IPO was priced at HK$17.50 per share, with a net raise of HK$2,463 billion.
Baiyun Mountain (600332.SH): Branch drugs passed generic drug consistency evaluation
Gelonghui, April 22丨Baiyunshan (600332.SH) announced that the company's branch Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceutical General Factory (“Baiyunshan Pharmaceutical General Factory”) received the “Drug Supplement Application Approval Notice” issued by the State Drug Administration. Cefixime tablets have passed the consistent evaluation of the quality and efficacy of generic drugs.
Express News | Baiyunshan: Cefixime tablets have passed the consistent evaluation of generic drug quality and efficacy
白雲山:2023年年報
Baiyun Mountain (600332.SH): Sildenafil citrate receives approval notice for application for marketing of chemical raw materials
Gelonghui, April 17, Baiyunshan (600332.SH) announced that the branch company Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Chemical Pharmaceutical Factory received a notice of approval for the marketing application of sildenafil citrate as a chemical ingredient approved and issued by the State Drug Administration on April 16, 2024. Sildenafil citrate is mainly used to treat erectile dysfunction.
Baiyunshan (00874.HK) plans to hold a board meeting on April 26 to approve quarterly results
Gelonghui, April 12, 丨 Baiyunshan (00874.HK) issued an announcement. The board of directors hereby announces that a board meeting will be held on April 26, 2024 (Friday) to review and approve the unaudited financial results of the company and its subsidiaries for the three months ended March 31, 2024 and handle other matters (if any).
BAIYUNSHAN PH: Date of Board Meeting
Express News | Baiyun Mountain: Wang Laoji's international English brand logo released in Los Angeles, USA
Multiple arrows in unison! Pharmaceutical innovation support policies are coming
Recently, many places, including Beijing, Guangzhou, and Zhuhai, have successively issued relevant policies (draft for comments) to support the high-quality development of the biomedical industry or innovative pharmaceutical devices. The intensive introduction of support policies and the tight schedule have attracted great attention from the industry.
Express News | Guojin Securities: Focus on opportunities such as in vitro diagnostic collection clean-up and proprietary Chinese medicine collection
No Data